See the full publication list on MyNCBI and Google Scholar.

Highlighted Publications:

Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predispositionDaichi Inoue, Jacob T. Polaski, Justin Taylor, et al.

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies

Screen Shot 2021-10-17 at 12.48.59 PM.png

A Moving Target: Inactivating BTK Mutations as Drivers of Follicular Lymphoma

Screen Shot 2021-10-17 at 12.52.45 PM.png

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trialJustin Taylor, et al.

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypo-methylating agents: a single-centre, single-arm, phase 2 trial

Screen Shot 2021-10-17 at 12.50.10 PM.png

Pirtobrutinib shows evidence to inaugurate a third generation of BTK inhibitors

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursorJustin Taylor, et al.Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

Screen Shot 2021-10-17 at 1.45.46 PM.png

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment

Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasmsJustin Taylor, et al.

Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms

Altered Nuclear Export Signal Recognition as a Driver of OncogenesisJustin Taylor, et al.

Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis

PTEN isoforms with dual and opposing functionJustin Taylor, et al.

PTEN isoforms with dual and opposing function

Spliceosomal disruption of the non-canonical BAF complex in cancer

Spliceosomal disruption of the non-canonical BAF complex in cancer

Mutations in spliceosome genes and therapeutic opportunities in myeloid malignanciesJustin Taylor, et al.

Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies

Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, et al.

Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies

Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations

Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, et al.

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

Somatic mutations and cell identity linked by Genotyping of TranscriptomesJustin Taylor, et al.

Somatic mutations and cell identity linked by Genotyping of Transcriptomes

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Diagnosis and classification of hematologic malignancies on the basis of genetics

Diagnosis and classification of hematologic malignancies on the basis of genetics